THE USE OF EMICIZUMAB IN A CHILD WITH HEMOPHILIA A INHIBITORY FOREMA

• Main Authors: Юлия Олеговна Рождественская (Author), Анастасия Владимировна Миронова (Author), Ирина Владимировна Болгова (Author), Яна Вячеславовна Юнкина (Author), Светлана Ивановна Елгина (Author), Вадим Гельевич Мозес (Author), Елена Владимировна Рудаева (Author), Наталья Степановна Черных (Author), Кира Борисовна Мозес (Author), Яэль Центер (Author)
• Format: Book
• Published: The Publishing House Medicine and Enlightenment, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hemophilia is a disease caused by hereditary deficiency of plasma coagulation factors VIII (FVIII) (hemophilia A) or IX (FIX) (hemophilia B) and characterized by hematomic bleeding. The main therapeutic measures in patients with hemophilia are aimed at replacing the deficient factor both during hemo...